These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22401888)

  • 1. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
    Smith SM; Dworkin RH; Turk DC; McDermott MP; Eccleston C; Farrar JT; Rowbotham MC; Bhagwagar Z; Burke LB; Cowan P; Ellenberg SS; Evans SR; Freeman RL; Garrison LP; Iyengar S; Jadad A; Jensen MP; Junor R; Kamp C; Katz NP; Kesslak JP; Kopecky EA; Lissin D; Markman JD; Mease PJ; O'Connor AB; Patel KV; Raja SN; Sampaio C; Schoenfeld D; Singh J; Steigerwald I; Strand V; Tive LA; Tobias J; Wasan AD; Wilson HD
    Pain; 2020 Nov; 161(11):2446-2461. PubMed ID: 32520773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity Is Doing the Same Thing Over and Over and Expecting Different Results.
    Eisenach JC; Rice ASC
    Anesth Analg; 2022 Dec; 135(6):1128-1136. PubMed ID: 36384008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding light on neuropathic pain: Current and emerging tools for diagnosis, screening, and quantification.
    Hamdan A; Galvez R; Katati M
    SAGE Open Med; 2024; 12():20503121231218985. PubMed ID: 38343869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential statistical principles of clinical trials of pain treatments.
    Dworkin RH; Evans SR; Mbowe O; McDermott MP
    Pain Rep; 2021; 6(1):e863. PubMed ID: 33521483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials.
    Smith SM; Fava M; Jensen MP; Mbowe OB; McDermott MP; Turk DC; Dworkin RH
    Pain; 2020 Sep; 161 Suppl 1(1):S3-S13. PubMed ID: 33090735
    [No Abstract]   [Full Text] [Related]  

  • 6. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.
    Gewandter JS; Dworkin RH; Turk DC; McDermott MP; Baron R; Gastonguay MR; Gilron I; Katz NP; Mehta C; Raja SN; Senn S; Taylor C; Cowan P; Desjardins P; Dimitrova R; Dionne R; Farrar JT; Hewitt DJ; Iyengar S; Jay GW; Kalso E; Kerns RD; Leff R; Leong M; Petersen KL; Ravina BM; Rauschkolb C; Rice ASC; Rowbotham MC; Sampaio C; Sindrup SH; Stauffer JW; Steigerwald I; Stewart J; Tobias J; Treede RD; Wallace M; White RE
    Pain; 2014 Sep; 155(9):1683-1695. PubMed ID: 24865794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
    Wang SJ; Hung HM; O'Neill R
    J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.
    Xie F; Ji Y; Tremmel L
    Contemp Clin Trials; 2012 Jul; 33(4):739-48. PubMed ID: 22426247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating the development of improved analgesic treatments: the ACTION public-private partnership.
    Dworkin RH; Turk DC
    Pain Med; 2011 Jul; 12 Suppl 3():S109-17. PubMed ID: 21752182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.
    Jenkins M; Stone A; Jennison C
    Pharm Stat; 2011; 10(4):347-56. PubMed ID: 22328327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early phase drug development for treatment of chronic pain--options for clinical trial and program design.
    Kalliomäki J; Miller F; Kågedal M; Karlsten R
    Contemp Clin Trials; 2012 Jul; 33(4):689-99. PubMed ID: 22401888
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.